Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: TPG Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 22, 2024 | TPG Inc. | Gift | −37,967 | — | — |
| Oct 15, 2024 | CeriBell Inc. | Derivative conversion | +3,587,154 | — | — |
| Oct 15, 2024 | CeriBell Inc. | Open-market purchase | +380,268 | $17.00 | $6,464,556 |
| Sep 16, 2024 | Bicara Therapeutics Inc. | Derivative conversion | +1,960,425 | — | — |
| Aug 14, 2024 | Life Time Group Holdings Inc. | Open-market sale | −3,575,000 | $20.88 | $74,646,000 |
| Feb 29, 2024 | Cushman & Wakefield Ltd. | Open-market sale | −7,734,954 | $9.74 | $75,338,452 |
| Feb 29, 2024 | TPG Inc. | Open-market sale | −1,516,949 | $41.64 | $63,165,756 |
| Feb 29, 2024 | TPG Inc. | Open-market sale | −16,949 | $41.64 | $705,756 |
| Feb 29, 2024 | TPG Inc. | Open-market sale | −33,899 | $41.64 | $1,411,554 |
| Feb 29, 2024 | TPG Inc. | Open-market sale | −16,949 | $41.64 | $705,756 |
| Feb 29, 2024 | TPG Inc. | Open-market sale | −16,949 | $41.64 | $705,756 |
| Feb 27, 2024 | TPG Inc. | Option exercise | +1,500,000 | — | — |
| Nov 20, 2023 | TPG Inc. | Gift | −400,000 | — | — |
| Nov 7, 2023 | Cushman & Wakefield Ltd. | Open-market sale | −10,000,000 | $7.63 | $76,300,000 |
| Aug 7, 2023 | Progyny Inc. | Open-market sale | −2,900,000 | $41.08 | $119,132,000 |
Questions about David Bonderman
What boards is David Bonderman on?
David Bonderman sits on the boards of Nerdy Inc. and TPG Inc.
How long has David Bonderman served on boards?
Our records show at least 7 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.